UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~______________~~ —————

FORM 8-K

~~______________~~ —————

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~September~~July 1327, ~~2019~~2020

~~______________~~ —————

TURNKEY CAPITAL, INC.

(Exact name of registrant as specified in its charter)

~~______________~~ —————


Nevada	333-186282	33-1225521
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

2929 East Commercial Blvd., PH-D, Fort Lauderdale, FL 33308

(Address of Principal Executive Office) (Zip Code)

954-440-4678

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company ¨

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

~~ITEM~~Item 1.01 ~~ENTRY~~Entry ~~INTO~~into Aa ~~MATERIAL~~Sale ~~DEFINITIVE~~of ~~AGREEMENT~~a Material Definitive Agreement.

OnAs previously disclosed on September 13, 2019, TurnKey Capital, Inc. (~~“We” or~~ the “Company”) entered into a Definitive Acquisition Agreement (the “TKCI DAA”) with Egg Health Hub, Inc., ~~a Florida corporation,~~ (“EGG”). Pursuant to the TKCI DAA, EGG and the Company ~~will~~agreed to commence the negotiation and preparation of a definitive share exchange agreement (the “Definitive Agreement”) whereby EGG will exchange all of its issued and outstanding shares of common stock for shares of the Company’s common stock on a one-for-one basis, which upon the completion of such Definitive Agreement will constitute 70,000,000 shares of EGG’s issued and outstanding common stock. Upon completion of such Definitive Agreement, EGG will become a wholly owned subsidiary of the Company.

EGG is a brand new model for healthcare and wellness that brings together top physicians and wellness professionals into co-practicing communities with shared access to a full-stack technology platform – scheduling, billing, client acquisition, and telemedicine – and flexible access to beautiful office space designed to optimize both the physician and client experience. ~~This~~The Company believes this model creates a compelling new option for re-tenanting traditional shopping centers and mixed-use space that landlords see as a true traffic generator.

~~The~~On ~~foregoing~~July ~~description~~27, of2020, the ~~terms~~Company and MediXall Group, Inc. (“MediXall”), a related party, entered into an assignment of the TKCI DAA. isAs ~~qualified~~a result of the COVID-19 outbreak, the Company determined that the original opportunity that existed with EGG was no longer practical in ~~its~~the ~~entirety~~short-term. byThe ~~reference~~Company toand MediXall believed, however, that the ~~provisions~~EGG ofconcept remained a viable concept on a virtual basis, and MediXall possesses the ~~agreement~~infrastructure ~~filed~~and aswillingness ~~Exhibit~~to 1pursue this opportunity. In exchange for 1,000,000 toshares ~~this~~of ~~Report~~MediXall’s common stock, ~~which~~the isCompany ~~incorporated~~assigned byits ~~reference~~interest ~~herein~~in the TKCI DAA to MediXall.

~~ITEM~~The 8foregoing description of the terms of the assignment of the TKCI DAA is qualified in its entirety by reference to the provisions of the agreement filed as Exhibit 10.011 ~~OTHER~~to ~~EVENTS~~this Current Report on Form 8-K, which is incorporated by reference herein.

InItem ~~connection with the Definitive Acquisition Agreement, the Company effectuated a reverse stock split (the “Split”) effective September 13, 2019~~9.01 ~~The~~— ~~Split~~Financial ~~was~~Statements ~~a 1-for-100 reverse stock split of the Company’s issued~~ and outstanding shares as of September 13, 2019. Prior to the Split, the Company had 42,264,665 issued and outstanding shares of its common stock. Effective at the opening of trading on the OTCQB on September 13, 2019, the Company had 422,647 shares of issued and outstanding shares of its common stock. Also, effective September 13, 2019, the Company began trading under the new CUSIP number 90042T107 for the Company’s common stock. The Company’s common stock will trade on the OTCQB under the same ticker symbol, TKCI. FINRA approved the reverse stock split on September 11, 2019.Exhibits

On(d) September 13, 2019, the Company issued a press release announcing the execution of the TKCI DAA. A copy of the press release is furnished as Exhibit 99.1 hereto and is hereby incorporated by reference.Exhibits

~~ITEM 9~~10.011 ~~FINANCIAL~~Definitive ~~STATEMENTS~~Acquisition ~~AND~~Agreement ~~EXHIBITS~~dated July 27, 2020 between the Registrant and MediXall Group, Inc.

~~(d) Exhibits.~~ SIGNATURE

Exhibit No.		Exhibit Description
1.1		Definitive Acquisition Agreement dated September 13, 2019
99.1		Press Release of TurnKey Capital, Inc., dated September 13, 2019

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SIGNATURE



Dated: July 29, 2020	TURNKEY CAPITAL, INC.

	By:	/s/ Timothy Hart
		Timothy Hart,
		Chief Financial Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: September 13, 2019

TURNKEY CAPITAL, INC.

/s/ Timothy Hart

Timothy Hart,

Treasurer and Secretary

Filing Compare · TurnKey Capital, Inc.